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Abstract Aggregation is a serious obstacle for recovery
of biologically active heterologous proteins from inclusion
bodies (IBs) produced by recombinant bacteria. E. coli
transformed with a vector containing the cDNA for
Bothropstoxin-1 (BthTx-1) expressed the recombinant
product as IBs. In order to obtain the native toxin, insoluble
and aggregated protein was refolded using high hydrostatic
pressure (HHP). IBs were dissolved and refolded (2 kbar,
16 h), and the effects of protein concentration, as well as
changes in ratio and concentration of oxido-shufﬂing
reagents, guanidine hydrochloride (GdnHCl), and pH in the
refolding buffer, were assayed. A 32% yield (7.6 mg per
liter of bacterial culture) in refolding of the native BthTx-1
was obtained using optimal conditions of the refolding
buffer (Tris–HCl buffer, pH 7.5, containing 3 mM of a 2:3
ratio of GSH/GSSG, and 1 M GdnHCl). Scanning electron
microscopy (SEM) showed that that disaggregation of part
of IBs particles occurred upon compression and that the
morphology of the remaining IBs, spherical particles, was
not substantially altered. Dose-dependent cytotoxic activity
of high-pressure refolded BthTx-1 was shown in C2C12
muscle cells.
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Introduction
Myotoxins are widespread components in venoms of
snakes from different genera. They are responsible for
intense disruption of muscle cells in tissues adjacent to the
bite site, thus contributing to the severity of accidents and
permanent sequelae that may occur in the most severe
cases [1]. These toxins belong to two major structural
groups. One that includes short-chain peptides, such as
crotamine and myotoxin A [2], while the other is composed
of molecules with phospholipase A2 (PLA2) structure [3].
Toxins of the latter group display structural motifs typical
of mammalian inﬂammatory PLA2s, in which 14 cysteine
residues responsible for the assembly of seven disulﬁde
bonds are conserved and the scaffold is highly preserved
[4]. In addition to myotoxic activity, snake venom PLA2s
may present pharmacological activities with anticoagulant,
neurotoxic, or cardiotoxic properties [5]. Many myotoxins
in this group are almost inactive when assayed in the usual
mixed-micelle enzyme tests because they display critical
substitutions within the calcium-binding loop [6]. These
include Q4/E, Y28/Q, and D49/K mutations [7]. Toxins
bearing these features are commonly referred to as K49
myotoxins. Although K49 toxins are enzymatically inac-
tive, they induce severe myonecrosis. Their activities are
comparable to their catalytically active counterparts [8]b y
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characterize these toxins and their mechanisms of action,
studies using site-directed mutagenesis would be helpful.
However, expression of biologically active recombinant
K49 myotoxins is a challenging task, especially because of
the high number of disulﬁde bonds, and solubilization and
refolding of such proteins from IBs using classical
refolding protocols usually result in low yields.
In traditional techniques for protein refolding, high
concentrations of chaotropic agents, such as GdnHCl and
urea, are used to solubilize recombinant IBs. Unfolded
proteins are then refolded by reduction in the concentration
of the chemical denaturants either by dilution or by chro-
matographic procedures, such as size-exclusion chroma-
tography, on-column or immobilized chaperone-assisted
refolding [9]. However, these conventional refolding
methods frequently allow generation of new aggregates
during the process of chaotropic agent removal, resulting in
low levels of protein in the soluble and native states.
The ability of high hydrostatic pressure (HHP) to dis-
sociate oligomeric proteins was theoretically predicted and
experimentally conﬁrmed [10]. High pressure acts on
protein structure favoring molecular transitions that reduce
system volume. Speciﬁc volumes in aggregated proteins
are larger than in native states due to the presence of
intermolecular water-excluded cavities. HHP in the range
1–3 kbar disfavor intermolecular hydrophobic and elec-
trostatic interactions leading to protein disaggregation
[11–13]. The same types of interaction are also responsible
for protein structure in the native states. However, typically
proteins do not denature until pressures above 5 kbar at
room temperature are reached. Thus, dissociation of mac-
romolecular complexes by HHP is not accompanied by
looseness of the existing secondary and tertiary structures
of the dissociated states. In the preceding decade, disso-
lution and refolding of some recombinant proteins pro-
duced as IBs in E. coli [14–19] and aggregated proteins
[20–22] were described.
Refolding of the toxin Bothropstoxin-1 (BthTx-1), a
small protein (13.7 kDa) containing seven disulﬁde
bridges, was previously obtained by solubilization of IBs
under denaturing conditions followed by size-exclusion
chromatography in the presence of surfactants with a 2.5%
yield of the native form [23].
Due to the high amount of cysteine residues in the native
BthTx-1 molecule, it is unavoidable that structures with
many intra- and inter-chain bond combinations arise with
the use of conventional methods to refold denatured
BthTx-1. In such condition, obtaining properly refolded
molecules, with correct disulﬁde bonds and toxic activity,
is a rather difﬁcult task to be achieved, and this makes
BthTx-1 refolding a challenging objective.
Materials and Methods
BthTx-1 Expression and IB Preparation
The expression plasmid pET24-BthTX-1, which contains
codons for translation of a protein with a Met residue,
followed by the sequence of BthTx-1, was transformed by
electroporation in competent E. coli BL21 cells. For
BthTx-1 expression, a culture was carried out in a 1000 ml
shake ﬂask containing 250 ml of rich culture medium
(2x-HKSII) supplemented with kanamycin (50 lg/ml). The
ﬂasks were inoculated with a pre-cultivated medium
(20 ml) containing E. coli harboring the expression plas-
mid and incubated (37C) in a rotary shaker until optical
density (OD600 nm) of the culture reached the value of 3.0.
Protein expression was then induced with addition of iso-
propyl b-D-thiogalactopyranoside IPTG (0.5 mM, ﬁnal
concentration) and the cultures were grown for 16 addi-
tional hours and harvested by centrifugation. The pellets
were resuspended in Tris–HCl (50 mM, 50 ml, pH 7.5),
containing EDTA (2 mM), Triton X-100 (0.1%, v/v) and
50 lg/ml lysozyme and incubated at 25C for 15 min. The
suspension was sonicated and centrifuged (8,0009g,4 C,
10 min). The supernatant was discarded; the pellet was
resuspended in 50 ml Tris–HCl (50 mM, pH 7.5), EDTA
(2 mM), and Triton X-100 (0.1%, v/v). The centrifugation
and resuspension steps were repeated ﬁve times; the
resulting pellet was dissolved in Tris–HCl (50 mM, pH
7.5), resuspended in the same buffer and stored (-20C)
for further assays.
Formulation of Refolding Buffers and Sample
Compression Assays
Suspensions of IBs were diluted in refolding buffer
(50 mM Tris–HCl, pH 7.5, 1 mM EDTA) containing dif-
ferent proportions of GSH/GSSG and concentrations of the
redox pair, GdnHCl or different pHs, as indicated in
Table 1 and Fig. 1. Suspension samples (1.0 ml) were
placed into plastic bags, which were sealed and placed into
a larger plastic bag, which was also sealed under vacuum.
This bag was then placed into a pressure vessel (High
Pressure Equipment, Model R4-6-40) ﬁlled with a mixture
of water and oil as pressure-transmitting ﬂuid and, high
pressure (2 kbar) was applied (16 h) using an air com-
pressor ﬁtted to the system (High Pressure Equipment,
Model PS-40). After decompression, the samples were
centrifuged (12,0009g, 15 min) to remove the insoluble
aggregates. The supernatants were dialyzed, centrifuged
again to remove insoluble aggregates formed during dial-
ysis and stored (-20C) for later analysis. All assays were
performed at least twice.
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Insoluble (IBs) and soluble BthTx-1 were diluted in Tris–
HCl (50 mM, pH 7.5) buffer containing urea (8 M) at
appropriate ratios, and submitted in duplicate to total pro-
tein determination (Bradford assay). An absorbance curve
(Anm) for pure bovine serum albumin (BSA; 15–500 lg/ml;
Bradford assay) samples was used as a standard. The same
samples were also submitted to both SDS-PAGE and
staining with Coomassie blue. Digital densitometry of
BthTx-1 bands was determined using the Image J software.
Scanning Electron Microscopy
Scanning electron microscopy (SEM) was performed after
drying water-dialyzed insoluble aggregates (IB or the non-
refolded aggregates) onto clean polished Philips stubs and
sputter-coated in a sputter coater (Balzer, model SCD-040,
38 mA, 120 s). The samples were then examined and
photographed in a Field Emission Scanning Electron
Microscope (JEOL, JSM 670-1F). Size analysis of IBs was
performed using the Image Tools software.
Cytotoxic Activity
C2C12 (ATCC CRL-1772), a murine skeletal myoblast cell
line which can fuse and differentiate into myotubes, was
grown in Dulbecco’s Modiﬁed Eagle’s Medium (DMEM;
Sigma D-5796) supplemented with 10% fetal calf serum,
2 mM glutamine, 1 mM pyruvic acid, penicillin (100 U/
ml), streptomycin (0.1 mg/ml), and amphotericin B
(0.25 lg/ml), in a humiﬁed atmosphere with 5% CO2,a t
Table 1 Analysis of the soluble BthTx-1 obtained by pressurization
of IBs suspensions
Soluble protein recovery (%)
a
GSH:GSSG proportion
1:9 n.d.
1:4 4.4
2:3 7.0
1:2 2.5
1:1 n.d.
2:1 n.d.
3:2 n.d.
4:1 n.d.
9:1 n.d.
2GSH:3GSSG concentration (mM)
0 n.d.
0.7 n.d.
1.5 n.d.
3.0 9.6
6.0 7.2
10.0 n.d.
20.0 n.d.
pH
5.5 21.2
6.5 12.5
7.5 18.2
8.5 5.0
9.0 n.d.
GndHCl concentration (M)
0 n.d.
0.25 n.d.
0.5 n.d.
0.75 n.d.
1 9.7
2 14.5
4 13.2
6 n.d.
IBs optical density (600 nm)
0.5 33.6
1.0 24.6
2.0 14.0
4.0 n.d.
6.0 n.d.
8.0 n.d.
Quantiﬁcation of SDS-PAGE stained bands. Effect of glutathione redox
pair ratios: Refolding buffer pH 7.5 containing 2 M GdnHCl and 10 mM
GSH/GSSG; Effect of concentration of GSH/GSSG: Refolding buffer pH
7.5 containing 2 M GdnHCl and a 2GSH:3GSSG ratio; Effect of pHs:
Refolding buffer, MES for pHs up to 6.5 and Tris–HCl for pHs 7.5 and
higher, containing 2 M GdnHCl and 3 mM glutathione at a 2GSH:3GSSG
ratio; Effect of concentration of GdnHCl: Refolding buffer, pH 7.5, con-
taining 3 mM glutathione at a 2GSH:3GSSG ratio; Effect of OD600 nm
readings: Refolding buffer, pH 7.5 containing 1 M GdnHCl and 3 mM
glutathione at a 2GSH:3GSSG ratio
n.d. non-detected
a The intensity of BthTX-1 bands was determined by digital densitometry
analysis
Fig. 1 Gel electrophoresis image showing the process phases, from
the raw inclusion bodies to the ﬁnal soluble active protein using
refolding buffer containing 3 mM glutathione at a 2:3 ratio of the
redox pair GSH/GSSG with IBs at 0.5 OD600 nm. Lane 1: molecular
mass marker; Lane 2: total bacteria before induction; Lane 3: total
bacteria after induction with isopropyl b-D-thiogalactopyranoside
(IPTG); Lane 4: IBs (insoluble fraction) before compression; Lane 5:
IBs (insoluble fraction) after compression; Lane 6: insoluble fraction
formed after compression and dialysis; Lane 7: soluble fraction after
compression and dialysis; Lane 8: soluble fraction after maintenance
at atmospheric pressure and dialysis. Arrow indicates molecular mass
of BthTX-1 monomer
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12337C. C2C12 cells were seeded in 96-well microplates, at
an approximate initial density of 1–4 9 10
3 cells per well.
After reaching near conﬂuence, usually in 3–5 days,
medium was replaced by differentiation medium, which
consisted of DMEM supplemented with 1% FCS. After 4–6
additional days of culture, cells were incubated with
BthTx-1 puriﬁed from crude venom, used as a control or
recombinant BthTx-1 refolded at high pressure, diluted in a
total of 250 ll culture medium/well. After 4 h incubation,
aliquots of the supernatant were collected and LDH activity
was determined using a commercial kit (LDH Liquiform-
Labtest) and expressed as percentage of LDH release [24].
Reference control for 100% LDH release consisted of
supernatant of cells incubated with medium from cells
incubated with 0.1% (v/v) of Triton X-100. The assays
were carried out in triplicates.
Results
Effect of Refolding Buffer on the Solubilization
of BthTx-1 from IBs
The extraordinarily high number of free cysteine thiol
groups present in the native BthTx-1 molecule was regar-
ded as an indication that refolding of this protein could be
complicated by the presence of non-native intra- and inter-
protein covalent disulﬁde bonds in IBs. Previous works
reported that HHP in combination with oxido-shufﬂing
agents, such as glutathione, can effectively refold cova-
lently cross-linked aggregates of recombinant proteins
produced as IBs in E. coli [16, 20]. In order to evaluate the
potential beneﬁt of this approach, suspensions of IBs were
incubated (2 kbar) in refolding buffer (50 mM Tris–HCl,
pH 7.5; 2 M GdnHCl) containing varying ratios of reduced
(GSH) and oxidized (GSSG) glutathione molecules at a
10 mM ﬁnal concentration. Presence of BthTx-1 in the
supernatants after compression followed by dialysis and
centrifugation, performed to withdraw the denaturing
reagent and insoluble aggregates eventually formed during
dialysis, was analyzed by SDS-PAGE (Table 1) and
quantiﬁcation of the bands of protein with a molecular
mass of about 14 kDa, corresponding to BthTx-1. The
sample of HHP-treated BthTx-1 exhibiting the most
intense band, was obtained with a 2:3 ratio of the
GSH:GSSG redox pair. For a ﬁxed 2 GSH:3 GSSG pro-
portion, 3 mM proved to be the total molar concentration
of the redox mixture in which the highest level of soluble
BthTx-1 was obtained for pressure-induced refolding. Low
(non-detectable) yields of soluble BthTx-1 was observed
for supernatant of suspensions of IBs incubated at HHP in
the absence of the redox pair, indicating that these reagents
are essential for BthTx-1 refolding.
Incubation of BthTx-1 (2 kbar, 16 h) was performed in
the presence of refolding buffer at various pHs (5.5–9.0)
and pH of 7.5 was chosen. A low value of intensity of band
was obtained at the sample compressed at pH 8.5, probably
due to protein precipitation at this pH near the pI value for
BthTx-1 (pI = 8.2).
Presence of additives at concentrations usually reported
in the literature for protein refolding [25] (0.1% polyeth-
ylene glycol 6000, 0.5 M arginine, 2.5 M glycerol, 1 M
sucrose, 1 M glucose, 0.1 M Tween-20, 0.5 mM Triton
X-100, and 0.15 M NaCl) did not improve the yields of
soluble BthTx-1 (data not shown).
Presence of non-denaturing levels of GdnHCl was pre-
viously shown to improve the yields of refolding of
aggregated proteins subjected to HHP. Pressurized BthTx-
1 IBs were not solubilized in the absence of GdnHCl, as
can be seen in the analysis of the SDS-PAGE bands
(Table 1). Higher yields of soluble BthTx-1 were obtained
in the presence of 2 and 4 M GdnHCl. The band of BtxTh-
1 corresponding to the sample compressed in the presence
of 1 M GdnHCl presented a slightly lower intensity. The
lowest concentration (1 M) was used in the following
experiments due to a higher probability of maintaining the
secondary and tertiary native structures of BtxTh-1, which
were previously shown to exist in IBs produced by E. coli
in the absence or in presence of low concentration of
denaturing reagent [26, 27]. At 6 M GdnHCl the yield of
soluble BthTx-1 diminishes, indicating that the protein was
solubilized but did not fold correctly, thus being more
prone to aggregation during dialysis.
The concentration of the aggregated protein can also be
an important parameter, since the correct refolding path-
way competes with the misfolding and aggregation ones.
Usually, low protein concentrations (typically 50–100 lg/
ml) are required to prevent reaggregation and thus higher
yields of refolded protein are obtained when traditional,
chemically induced solubilization of aggregated proteins
are used in refolding. Table 1 shows that the yields of
soluble BthTx-1 obtained after compression (2 kbar) and
dialysis were proportional to the dilutions of IBs. Thus, we
choose a low BthTX-1 concentration (O.D. of 0.5), which
corresponds to a protein concentration of approximately
50 lg/ml, for the HHP refolding.
ASDS-PAGEimageshowingthephasesintheprocessof
obtaining soluble BthTx-1 is shown in Fig. 1. Expression of
BthTx-1 by activated E. coli cells is low (lane 3). However,
enrichment of insoluble BthTx-1 occurred after the cells
weresonicatedandIBswerewashed,asshowninlane4.The
sample treated with compression at optimal conditions is
shown in lane 7 as a very strong and nearly unique band. As
canbeobservedinlane8(samplemaintainedatatmospheric
pressure), the BthTx-1 band is very faint, indicating that the
protein was not solubilized/refolded under this condition.
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amount of 7.6 mg of BthTx-1 was obtained from 1 l of
bacterial culture.
The immunological identity of BthTx-1 was conﬁrmed
by western blot analysis (not shown).
Visualization of IBs and Insoluble Aggregates
Insoluble samples of BthTx-1, non-treated (A) or treated
(B) with 2 kbar pressure (16 h) in refolding buffer (50 mM
Tris–HCl, pH 7.5, 1 mM EDTA, 3 mM glutathione, 2:3
ratio of GSH/GSSG, and 1 M GdnHCl), are shown in
Fig. 2. The IBs were mostly regular spherical particles with
an average diameter of 0.27 ± 0.032 lm. Although less
dense material was observed, the morphology and size of
the insoluble particles remaining after 2.0 kbar application
was similar to the non-treated IBs, suggesting that the high
pressure was not able to induce solubilization of all the IBs
particles.
Biological Activity Determination
BthTx-1 is a myotoxic protein, which shows lytic activity
on differentiated muscle cells [24]. BthTx-1 cytotoxicity
was estimated by the release of LDH to supernatant after
incubation with the toxin for 4 h. Figure 3 shows LDH
activity in the supernatant of C2C12 muscle cells treated
with the refolded toxin and with the natural one, puriﬁed
from B. jararacussu venom. The cytotoxic effect induced
by the recombinant protein at the concentration of
30–120 lg/ml was comparable to the activity of the natural
toxin thus validating our refolding procedure. Dose-
dependent cytolytic activity of BthTx-1 refolded under
HHP is shown for C2C12 cells.
Discussion
Our strategy for expression of BthTx-1 resulted in pro-
duction of this toxin within IBs, which were easily sepa-
rated from soluble bacterial proteins by centrifugation.
Starting from IBs, dissociation of the insoluble aggre-
gates was a problem to be solved. In order to obtain protein
refolding, traditional approaches use high concentrations of
Fig. 2 Field scanning electron
microscopy (SEM) of insoluble
BthTx-1. a IBs; b insoluble
aggregates after compression.
Scale bars:1 0lm (original
magniﬁcation 91000), 1 lm
(original magniﬁcation
910,000)
Fig. 3 Cytotoxicity was determined by the release of LDH to cell
supernatants, 4 h after exposure of the cells to recombinant BthTx-1
refolded under high pressure or to BthTx-1from crude venom. Each
bar represents mean ± SD of triplicate cultures
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123chemical denaturing reagents for disaggregation that also
results in essentially complete unfolding of protein mole-
cules. Thus, interactions between non-native protein mol-
ecules occur during removal of the denaturing reagent and
strong re-aggregation is usually observed [5]. Together
with misfolded states, native proteins with secondary and
even certain amount of tertiary structures were shown in
bacterial recombinant IBs [26, 27]. It has also been shown
that use of mild conditions for solubilization of IBs favors
maintaining native structures [18, 28, 29], thus precluding
re-aggregation. Dissolution of covalently cross-linked
aggregates requires disruption of non-native hydrophobic
contacts, electrostatic interactions, and hydrogen and
disulﬁde bonds. HHP has been reported to disrupt both
ionic and hydrophobic interactions. However, hydrogen
bonds are pressure insensitive [13] and non-native hydro-
gen bonds among aggregated molecules can interfere with
pressure-induced dissolution. It has already been shown
that presence of low concentrations of GdnHCl can favor
disruption of those bonds allowing dissolution of aggre-
gated states [18]. Since HHP favors protein disaggregation,
we solubilized BthTx-1 under a non-denaturing condition
and low concentration (1 M) of GdnHCl, a condition
milder than that described for solubilization of BthTx-1 IBs
under atmospheric pressure and denaturing conditions [23].
Usually, high number of disulﬁde bonds makes refold-
ing procedures difﬁcult. BthTx-1 contains seven disulﬁde
bonds [30]. Addition of redox shufﬂing agents to covalently
cross-linked aggregates facilitates refolding of disulﬁde-
containing proteins by breaking non-native intermolecular
disulﬁde bonds under conditions that allow these bonds to
be formed [19]. As expected, both the redox pair GSH/
GSSG ratio and glutathione concentration were shown to be
essential for the recovery of BthTx-1 in the refolding pro-
cess. We found that the optimal ratio and concentration for
these reagents were 2GSH:3GSSG and 3 mM, respectively.
The pH value of 7.5 was chosen for HHP-driven dissolution
and refolding of BthTx-1.
The effects of additives on refolding yields of native
proteins have been tested with traditional refolding proto-
cols. Although the mechanism of action of these com-
pounds is not well understood, empirical screening of
dissolution additives occasionally led to formulations that
substantially increase the refolding yield at atmospheric
pressure [31, 32]. The effect of the presence of some
additives on HHP-refolding has also been tested. Arginine
(0.5 M) combined with HHP was most effective to obtain
three functional Gram-negative binding proteins (GNBP1,
GNBP2, and GNBP3) and two human phosphatases from
IBs [21]. In this study, none of the additives tested further
enhanced the yields of refolded BthTx-1.
Although BthTx-1 3-D structure is identical to that of
PLA2, this protein is unable to bind Ca
2? due to a D49/K
mutation and is therefore devoid of the catalytic activity
characteristic of this class of enzyme. For this reason,
phospholipase activity was not used to determine BthTx-1
bioactivity. LDH detection assays in myoblasts or myotu-
bule cultures treated with BthTx-1 were performed. Our
results showed that the protein refolded under pressure
exhibit cytolytic activity, indicating that the treatment led
to the formation of BthTx-1 with biofunctional structure.
In conclusion, solubilization and refolding of high levels
of biologically active BthTx-1 was achieved using HHP.
We obtained 32% of BthTx-1 refolding, a yield much
higher than that previously described (2.5%) [23], in which
denaturing conditions were used for solubilization of IBs.
Several authors [33–36] have expressed recombinant
snake PLA2s, mostly aiming the obtention of mutants for
structure–function studies. However, in most cases, the
yields of properly refolded proteins, using classical proto-
cols were fairly low, fact that might be ascribed to the 7
disulﬁde bonds that reticulate the toxin and might form
intra and inter-molecular bonds during the refolding pro-
cess. We believe that our approach might represent an
attractive alternative to circumvent this difﬁculty, a mile-
stone for future site-directed mutagenesis studies, which
are so necessary for further understanding the mechanism
of action of these toxins.
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